2012年-2017年
院内がん登録年別集計（UICC第7版）
| 部位／年 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|---|
| 食道 | 48 | 72 | 64 | 67 | 87 | 81 |
| 胃 | 283 | 282 | 287 | 261 | 272 | 234 |
| 結腸 | 146 | 168 | 174 | 171 | 212 | 190 |
| 直腸 | 86 | 84 | 98 | 105 | 118 | 93 |
| 肝 | 61 | 66 | 60 | 43 | 44 | 49 |
| 肝内胆管 | 17 | 13 | 6 | 10 | 13 | 14 |
| 胆のう | 11 | 9 | 16 | 21 | 12 | 13 |
| 肝外胆管 | 32 | 29 | 24 | 23 | 25 | 17 |
| 膵臓 | 85 | 69 | 87 | 91 | 102 | 100 |
| 肺（小細胞肺癌を除く） | 125 | 143 | 146 | 168 | 177 | 157 |
| 乳房 | 54 | 95 | 80 | 81 | 117 | 88 |
| 前立腺 | 68 | 48 | 60 | 49 | 69 | 81 |
| 膀胱 | 31 | 34 | 25 | 23 | 38 | 31 |
| 子宮頸部 | 57 | 44 | 50 | 87 | 85 | 72 |
| 子宮体部 | 23 | 26 | 20 | 18 | 23 | 20 |
部位・病期別５年実測生存率（2012年－2014年症例 UICC第7版）
| 部位/ステージ | 0 | I | II | III | IV | 追跡率 | グラフ 表示 |
|
|---|---|---|---|---|---|---|---|---|
| 食道 | 症例数 | 22 | 69 | 22 | 45 | 26 | 100.0% | |
| 生存率 | 77.3% | 76.8% | 36.4% | 22.2% | 0.0% | |||
| 胃 | 症例数 | / | 525 | 105 | 89 | 133 | 99.1% | |
| 生存率 | / | 82.8% | 67.1% | 38.0% | 6.9% | |||
| 結腸 | 症例数 | 50 | 95 | 127 | 130 | 86 | 99.5% | |
| 生存率 | 84.0% | 88.4% | 74.0% | 72.9% | 16.3% | |||
| 直腸 | 症例数 | 14 | 60 | 78 | 75 | 41 | 99.6% | |
| 生存率 | 85.7% | 85.0% | 76.7% | 68.0% | 26.8% | |||
| 肝 | 症例数 | / | 94 | 36 | 44 | 13 | 99.4% | |
| 生存率 | / | 61.7% | 48.6% | 18.2% | 0.0% | |||
| 肝内胆管 | 症例数 | / | (7-9) | (4-6) | (4-6) | 16 | 100.0% | |
| 生存率 | / | 55.6% | 40.0% | 50.0% | 6.3% | |||
| 胆のう | 症例数 | 0 | (7-9) | (7-9) | (4-6) | 15 | 100.0% | |
| 生存率 | / | 75.0% | 71.4% | 16.7% | 0.0% | |||
| 肝外胆管 | 症例数 | (1-3) | 24 | 35 | 13 | 12 | 100.0% | |
| 生存率 | 100.0% | 50.0% | 14.3% | 7.7% | 0.0% | |||
| 膵臓 | 症例数 | 11 | (4-6) | 146 | 22 | 58 | 100.0% | |
| 生存率 | 36.4% | 75.0% | 21.2% | 4.5% | 5.2% | |||
| 肺 （小細胞癌を除く） |
症例数 | / | 153 | 41 | 78 | 142 | 99.7% | |
| 生存率 | / | 66.0% | 41.5% | 27.3% | 7.0% | |||
| 乳房 | 症例数 | 18 | 100 | 80 | 19 | 12 | 100.0% | |
| 生存率 | 100.0% | 92.0% | 93.8% | 73.7% | 41.7% | |||
| 前立腺 | 症例数 | / | 80 | 33 | 22 | 41 | 99.4% | |
| 生存率 | / | 81.1% | 87.9% | 81.8% | 31.7% | |||
| 膀胱 | 症例数 | 46 | 24 | (7-9) | (4-6) | (7-9) | 98.8% | |
| 生存率 | 64.4% | 58.3% | 25.0% | 60.0% | 28.6% | |||
| 子宮頸部 | 症例数 | 104 | 21 | (7-9) | 11 | (4-6) | 98.0% | |
| 生存率 | 100.0% | 85.7% | 77.8% | 45.5% | 16.7% | |||
| 子宮体部 | 症例数 | / | 48 | (4-6) | (7-9) | (4-6) | 100.0% | |
| 生存率 | / | 85.4% | 50.0% | 77.8% | 16.7% |
部位・病期別５年実測生存率（2015年－2017年症例 UICC第7版）
| 部位/ステージ | 0 | I | II | III | IV | 追跡率 | グラフ 表示 |
|
|---|---|---|---|---|---|---|---|---|
| 食道 | 症例数 | 32 | 65 | 35 | 62 | 41 | 99.5% | |
| 生存率 | 68.8% | 63.1% | 51.4% | 32.3% | 5.0% | |||
| 胃 | 症例数 | / | 453 | 68 | 98 | 148 | 100.0% | |
| 生存率 | / | 79.2% | 63.2% | 36.7% | 2.7% | |||
| 結腸 | 症例数 | 98 | 122 | 165 | 102 | 86 | 100.0% | |
| 生存率 | 84.7% | 86.9% | 77.0% | 73.5% | 23.3% | |||
| 直腸 | 症例数 | 43 | 81 | 64 | 88 | 40 | 100.0% | |
| 生存率 | 76.7% | 87.7% | 76.6% | 69.3% | 7.5% | |||
| 肝 | 症例数 | / | 56 | 28 | 42 | 10 | 100.0% | |
| 生存率 | / | 60.7% | 46.4% | 19.0% | 0.0% | |||
| 肝内胆管 | 症例数 | / | (4-6) | (4-6) | (1-3) | 22 | 100.0% | |
| 生存率 | / | 83.3% | 42.9% | 50.0% | 9.1% | |||
| 胆のう | 症例数 | (4-6) | (1-3) | (4-6) | 13 | 24 | 100.0% | |
| 生存率 | 75.0% | 100.0% | 75.0% | 15.4% | 0.0% | |||
| 肝外胆管 | 症例数 | (1-3) | 10 | 27 | (7-9) | 17 | 100.0% | |
| 生存率 | 66.7% | 70.0% | 37.0% | 0.0% | 5.9% | |||
| 膵臓 | 症例数 | 12 | 21 | 142 | 14 | 104 | 99.6% | |
| 生存率 | 100.0% | 47.6% | 18.3% | 0.0% | 1.0% | |||
| 肺 （小細胞癌を除く） |
症例数 | / | 221 | 65 | 90 | 126 | 99.8% | |
| 生存率 | / | 77.3% | 50.8% | 30.0% | 7.1% | |||
| 乳房 | 症例数 | 31 | 113 | 87 | 31 | 24 | 100.0% | |
| 生存率 | 96.8% | 96.5% | 88.5% | 74.2% | 25.0% | |||
| 前立腺 | 症例数 | / | 106 | 28 | 18 | 47 | 100.0% | |
| 生存率 | / | 80.2% | 71.4% | 66.7% | 48.9% | |||
| 膀胱 | 症例数 | 46 | 28 | (7-9) | (1-3) | (7-9) | 100.0% | |
| 生存率 | 80.4% | 64.3% | 50.0% | 66.7% | 0.0% | |||
| 子宮頸部 | 症例数 | 189 | 31 | (1-3) | 14 | (7-9) | 97.9% | |
| 生存率 | 100.0% | 87.1% | 66.7% | 71.4% | 14.3% | |||
| 子宮体部 | 症例数 | / | 44 | (4-6) | (4-6) | (4-6) | 100.0% | |
| 生存率 | / | 93.2% | 80.0% | 50.0% | 16.7% |
※ＵＩＣＣ7版に準拠しています。
※実測生存率とは、死因に関係なく、全ての死亡を計算に含めた生存率です。この中には、がん以外の死因による死亡も含まれます。